CNMD (STOCKS)
CONMED Corporation
$42.330000
-0.470000 (-1.10%)
Prev close: $42.800000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Patrick Joseph Beyer
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,350.97M
- Employees
- 3,900
- P/E (TTM)
- 28.34
- P/B (TTM)
- 1.31
- Dividend Yield
- 186.92%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
6
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$1.43 | $1.35 | +0.0802 | +5.94% |
|
Sep 2025 (Q3)
|
$1.08 | $1.07 | +0.0071 | +0.66% |
|
Jun 2025 (Q2)
|
$1.15 | $1.15 | +0.0042 | +0.37% |
|
Mar 2025 (Q1)
|
$0.95 | $0.83 | +0.1223 | +14.78% |
Financial Statements
| Revenues | $1.35B |
| Benefits Costs and Expenses | $1.26B |
| Cost Of Revenue | $616.94M |
| Costs And Expenses | $1.26B |
| Gross Profit | $730.53M |
| Operating Expenses | $612.04M |
| Selling, General, and Administrative Expenses | $557.88M |
| Research and Development | $54.16M |
| Operating Income/Loss | $118.50M |
| Income/Loss From Continuing Operations After Tax | $64.07M |
| Income/Loss From Continuing Operations Before Tax | $85.51M |
| Income Tax Expense/Benefit | $21.44M |
| Income Tax Expense/Benefit, Deferred | $9.29M |
| Interest Expense, Operating | $32.57M |
| Net Income/Loss | $64.07M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $64.07M |
| Net Income/Loss Available To Common Stockholders, Basic | $64.07M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $2.07 |
| Diluted Earnings Per Share | $2.05 |
| Basic Average Shares | 31,058,000 |
| Diluted Average Shares | 31,147,000 |
| Assets | $2.32B |
| Current Assets | $662.16M |
| Inventory | $364.36M |
| Other Current Assets | $297.80M |
| Noncurrent Assets | $1.66B |
| Fixed Assets | $112.04M |
| Intangible Assets | $593.11M |
| Other Non-current Assets | $955.19M |
| Liabilities | $1.31B |
| Current Liabilities | $314.70M |
| Accounts Payable | $107.09M |
| Wages | $76.13M |
| Other Current Liabilities | $131.49M |
| Noncurrent Liabilities | $999.53M |
| Equity | $1.01B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.01B |
| Liabilities And Equity | $2.32B |
| Net Cash Flow From Operating Activities | $167.69M |
| Net Cash Flow From Operating Activities, Continuing | $167.69M |
| Net Cash Flow From Investing Activities | -$17.89M |
| Net Cash Flow From Investing Activities, Continuing | -$17.89M |
| Net Cash Flow From Financing Activities | -$149.52M |
| Net Cash Flow From Financing Activities, Continuing | -$149.52M |
| Exchange Gains/Losses | $175.00K |
| Net Cash Flow | $462.00K |
| Net Cash Flow, Continuing | $287.00K |
| Comprehensive Income/Loss | $69.56M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $69.56M |
| Other Comprehensive Income/Loss | -$62.87M |